statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	760
RU - Federazione Russa	197
SG - Singapore	113
IE - Irlanda	90
CN - Cina	87
IT - Italia	76
BR - Brasile	47
VN - Vietnam	39
DE - Germania	31
FI - Finlandia	26
GB - Regno Unito	26
HK - Hong Kong	26
FR - Francia	25
SE - Svezia	18
ZA - Sudafrica	13
KR - Corea	12
CA - Canada	10
CZ - Repubblica Ceca	7
IN - India	6
PL - Polonia	6
BD - Bangladesh	5
MX - Messico	5
ES - Italia	4
JP - Giappone	4
KE - Kenya	4
AE - Emirati Arabi Uniti	3
AZ - Azerbaigian	3
EG - Egitto	3
IR - Iran	3
JO - Giordania	3
PK - Pakistan	3
TR - Turchia	3
AR - Argentina	2
AT - Austria	2
CI - Costa d'Avorio	2
EC - Ecuador	2
IQ - Iraq	2
NL - Olanda	2
TN - Tunisia	2
UA - Ucraina	2
AL - Albania	1
AU - Australia	1
BO - Bolivia	1
CH - Svizzera	1
CL - Cile	1
CO - Colombia	1
GE - Georgia	1
HN - Honduras	1
ID - Indonesia	1
JM - Giamaica	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LB - Libano	1
LK - Sri Lanka	1
LT - Lituania	1
LV - Lettonia	1
MA - Marocco	1
MD - Moldavia	1
MU - Mauritius	1
MY - Malesia	1
NI - Nicaragua	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
SR - Suriname	1
UY - Uruguay	1
VE - Venezuela	1
Totale	1.700

Nome	#
Left Ventricular Mass with Delayed Enhancement as a Predictor of Major Events in Patients with Myocarditis with Preserved Ejection Fraction	427
ADONHERS (Aged DONor HEart Rescue by Stress Echo) National Protocol: Recipient's Survival after 10-Year Follow-Up	190
Biomarkers predict in-hospital major adverse cardiac events in covid-19 patients: A multicenter international study	157
Two and Three-Dimensional Echocardiography in Primary Mitral Regurgitation: Practical Hints to Optimize the Surgical Planning	146
Risk stratification in cardiogenic shock: a focus on the available evidence	145
The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences	144
Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization	123
Biomarkers in Patients with Left Ventricular Assist Device: An Insight on Current Evidence	122
Current and emerging drug targets in heart failure treatment	107
Epidemiological and clinical boundaries of heart failure with preserved ejection fraction	98
Strain echocardiography for the prognostic estimation of patients with sarcoidosis	94
Totale	1.753

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	51	0	0	0	0	0	0	17	7	0	5	8	14
2022/2023	135	5	12	12	9	11	17	8	15	10	8	6	22
2023/2024	176	10	8	20	20	8	30	67	1	1	5	0	6
2024/2025	359	16	12	36	13	52	27	14	18	40	20	35	76
2025/2026	1.032	64	95	421	95	183	26	71	15	22	40	0	0
Totale													1.753